Literature DB >> 29779883

Gender Gap and Risk Factors for Poor Stroke Outcomes: A Single Hospital-Based Prospective Cohort Study.

Kuo-Hua Hung1, Jerry Cheng-Yen Lai2, Kuang-Nan Hsu3, Chihmin Hu3, Hung-Chang Chang4, Cheng-Neng Chen4, He-Shu Ku4, Ming-Shiang Yang5, Pei-Hao Chen6.   

Abstract

BACKGROUND: This study intended to investigate whether etiological stroke subtypes and their corresponding major risk factors have differential effects on outcomes between genders. PATIENTS AND METHODS: We enrolled 403 consecutive patients with first-ever acute ischemic stroke (170 women, 233 men), from a referral hospital in Taiwan over a 2-year period. Gender differences in demographics, vascular risk factors, access to health care, etiological stroke subtypes, stroke severity, and outcomes were examined. The primary outcome variable of the study was any unfavorable outcome due to acute ischemic stroke, defined as a modified Rankin Scale score of 3 or higher at 90 days after stroke. Multivariable logistic regression models were used to identify predictors of poor outcomes.
RESULTS: There were no gender disparities in baseline severity, stroke subtypes, access to health care, and medical comorbidities. Although women had poorer outcomes, female gender was not a predictor of unfavorable outcomes. Important predictors included age of 75years or older (odds ratio [OR] = 2.67; 95% confidence interval [CI], 1.46-4.90), National Institutes of Health Stroke Scale greater than or equal to 8 (OR = 8.38; 95% CI, 4.61-15.2), lack of cohabitation (OR = 2.13; 95% CI, 1.26-3.61), subtypes of cardioembolism (OR = 2.76; 95% CI, 1.29-5.93), and large-artery atherosclerosis (OR = 2.93; 95% CI, 1.47-5.85). In subgroup analyses, the gender-specific independent predictors were cardioembolism (OR = 7.42; 95% CI, 2.21-24.9) or atrial fibrillation (OR = 3.57; 95% CI, 1.31-9.74) in women, and large-artery atherosclerosis (OR = 3.35; 95% CI, 1.30-8.64) or symptomatic large-artery stenosis (OR = 3.42; 95% CI, 1.69-6.96) in men. The differential effects of these predictors according to gender were revealed by interaction tests.
CONCLUSION: Atrial fibrillation and symptomatic large-artery stenosis are predictors of poor stroke outcomes in women and men, respectively.
Copyright © 2018 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; cardioembolism; gender; large-artery atherosclerosis; stroke outcomes

Mesh:

Year:  2018        PMID: 29779883     DOI: 10.1016/j.jstrokecerebrovasdis.2018.04.014

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  4 in total

1.  Differences in Diagnostic Evaluation in Women and Men After Acute Ischemic Stroke.

Authors:  Samuel S Bruce; Alexander E Merkler; Meenakshi Bassi; Monica L Chen; Setareh Salehi Omran; Babak B Navi; Hooman Kamel
Journal:  J Am Heart Assoc       Date:  2020-02-28       Impact factor: 5.501

2.  Low self-reported sports activity before stroke predicts poor one-year-functional outcome after first-ever ischemic stroke in a population-based stroke register.

Authors:  Christian Urbanek; Viola Gokel; Anton Safer; Heiko Becher; Armin J Grau; Florian Buggle; Frederick Palm
Journal:  BMC Neurol       Date:  2018-11-03       Impact factor: 2.474

3.  Sex-Related Disparities in the Incidence and Outcomes of Ischemic Stroke among Type 2 Diabetes Patients. A Matched-Pair Analysis Using the Spanish National Hospital Discharge Database for Years 2016-2018.

Authors:  Ana López-de-Andrés; Rodrigo Jimenez-Garcia; Valentin Hernández-Barrera; Isabel Jiménez-Trujillo; José J Zamorano-León; David Carabantes-Alarcon; Marta Lopez-Herranz; José M de Miguel-Yanes; Javier de Miguel-Diez
Journal:  Int J Environ Res Public Health       Date:  2021-04-01       Impact factor: 3.390

4.  Sex differences in risk factors, treatment, and prognosis in acute stroke.

Authors:  Solveig Dahl; Clara Hjalmarsson; Björn Andersson
Journal:  Womens Health (Lond)       Date:  2020 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.